Point State Capital LP Avrobio, Inc. Transaction History

Point State Capital LP

  • $3.92 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$15.43 - $32.7 $1.68 Million - $3.56 Million
-108,750 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$26.95 - $52.7 $976,937 - $1.91 Million
-36,250 Reduced 25.0%
108,750 $5.64 Million
Q2 2018

Aug 14, 2018
BUY
$28.08 - $31.2 $4.07 Million - $4.52 Million
145,000 New
145,000 $4.14 Million

Others Institutions Holding AVRO

# of Institutions
2
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Point State Capital LP Portfolio

Follow Point State Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Point State Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email